QYUNS-B (02509) spent approximately 1.9994 million Hong Kong dollars to buy back 98,800 shares on February 2nd.

21:34 02/02/2026

China Biotech Holdings Limited (02509) announced that on February 2, 2026, it repurchased approximately 99,800 shares for approximately HK$1.99 million.

QYUNS-B (02509) announces that on February 2, 2026, it will buy back approximately 99,800 shares for about 1.99 million Hong Kong dollars.

Pagoda GP (02411) diluted its equity stake in Bai Guoyuan Commercial Management to 51.02%. The core management team increased its investment to expand into new business areas.

Tianli International Holdings (01773) director Luo Shi acquired an additional 1 million shares.

CHINA HEALTH (00673) issued a total of 40.638 million share options.

Pagoda GP (02411) diluted its equity stake in Bai Guoyuan Commercial Management to 51.02%. The core management team increased its investment to expand into new business areas.

Tianli International Holdings (01773) director Luo Shi acquired an additional 1 million shares.

CHINA HEALTH (00673) issued a total of 40.638 million share options.